WO2005042131A1 - Novel separation matrix - Google Patents

Novel separation matrix Download PDF

Info

Publication number
WO2005042131A1
WO2005042131A1 PCT/SE2004/001583 SE2004001583W WO2005042131A1 WO 2005042131 A1 WO2005042131 A1 WO 2005042131A1 SE 2004001583 W SE2004001583 W SE 2004001583W WO 2005042131 A1 WO2005042131 A1 WO 2005042131A1
Authority
WO
WIPO (PCT)
Prior art keywords
support
gradient
ligands
ligand
matrix
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/SE2004/001583
Other languages
English (en)
French (fr)
Inventor
Jan Bergström
Gunnar Glad
Bo-Lennart Johansson
Anders LJUNGLÖF
Jean-Luc Maloisel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cytiva Sweden AB
Global Life Sciences Solutions USA LLC
Original Assignee
Amersham Bioscience AB
GE Healthcare Bio Sciences Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amersham Bioscience AB, GE Healthcare Bio Sciences Corp filed Critical Amersham Bioscience AB
Priority to US10/575,945 priority Critical patent/US20070125711A1/en
Priority to JP2006537940A priority patent/JP2007510153A/ja
Priority to EP04800246A priority patent/EP1677887A1/en
Publication of WO2005042131A1 publication Critical patent/WO2005042131A1/en
Anticipated expiration legal-status Critical
Priority to US12/692,671 priority patent/US8070958B2/en
Ceased legal-status Critical Current

Links

Classifications

    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J20/00Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
    • B01J20/30Processes for preparing, regenerating, or reactivating
    • B01J20/32Impregnating or coating ; Solid sorbent compositions obtained from processes involving impregnating or coating
    • B01J20/3231Impregnating or coating ; Solid sorbent compositions obtained from processes involving impregnating or coating characterised by the coating or impregnating layer
    • B01J20/3242Layers with a functional group, e.g. an affinity material, a ligand, a reactant or a complexing group
    • B01J20/3285Coating or impregnation layers comprising different type of functional groups or interactions, e.g. different ligands in various parts of the sorbent, mixed mode, dual zone, bimodal, multimodal, ionic or hydrophobic, cationic or anionic, hydrophilic or hydrophobic
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J20/00Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
    • B01J20/281Sorbents specially adapted for preparative, analytical or investigative chromatography
    • B01J20/286Phases chemically bonded to a substrate, e.g. to silica or to polymers
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J20/00Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
    • B01J20/30Processes for preparing, regenerating, or reactivating
    • B01J20/32Impregnating or coating ; Solid sorbent compositions obtained from processes involving impregnating or coating
    • B01J20/3231Impregnating or coating ; Solid sorbent compositions obtained from processes involving impregnating or coating characterised by the coating or impregnating layer
    • B01J20/3242Layers with a functional group, e.g. an affinity material, a ligand, a reactant or a complexing group
    • B01J20/3244Non-macromolecular compounds
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01DSEPARATION
    • B01D15/00Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08Selective adsorption, e.g. chromatography
    • B01D15/26Selective adsorption, e.g. chromatography characterised by the separation mechanism
    • B01D15/36Selective adsorption, e.g. chromatography characterised by the separation mechanism involving ionic interaction, e.g. ion-exchange, ion-pair, ion-suppression or ion-exclusion
    • B01D15/361Ion-exchange
    • B01D15/364Amphoteric or zwitterionic ion-exchanger

Definitions

  • US 6,426,315 (Bergstr ⁇ m et al.) suggests to replace such a series of steps by using a multifunctional porous separation matrix, i.e. to present the different kind of matrices on a single separa- tion matrix. More specifically, US 6,426,315 relates to a process for preparing such multifunctional porous separation matrices by introducing different functionalities in different layers of the matrix.
  • the ionisable functionality is partially electrostatically charged at the pH of adsorption of the target compound to the resin, and is either further charged or of oppo- site charge at the pH of deso ⁇ tion of the compound from the resin.
  • the ionisable functionalities are selected from a specified group of possible functionalities.
  • the ionisable functional group is derived from either 2-mercapto-l- methylimidazole or (-)phenylpropanolamine and coupled to a density of at least 150 ⁇ mol per millilitre of resin.
  • Such a high ligand density is stated to provide a sufficient hydrophobicity to adsorb target compounds without the need of adding excessive amounts of salt to the liquid.
  • US 5,945,520 discloses multifunctional ligands evenly coupled to a resin, which consequently can be described as a homogenous separation matrix.
  • US 5,977,345 relates to an inside-out spatial installation method for a bifunc- tional reagent that crosslinks a polymer matrix. More specifically, this reference relates to an activated matrix, which can accommodate and optimize the spatial installation of affinity ligands while preventing the immobilization of excess ligand in the outer strata of the hydrogel bead.
  • One aspect of the present invention is to provide a separation matrix, wherein the mass transport properties during adso ⁇ tion and/or deso ⁇ tion have been improved. This can be achieved by a separation matrix as described in claim 1.
  • Figure 1 is a comparative ligand distribution plot of a prior art separation matrix with an even distribution of ligands.
  • the porous parti- cle is an essentially spherical bead.
  • the supports used in the present invention may be made of an inorganic material, such as glass or silica, or an organic material, such as one or more organic polymers. In an advantageous embodiment, the support is made from natural or synthetic polymers.
  • the deactivated groups on the surface of the support cannot react with the second reagent, and no functional groups with be coupled at these sites.
  • the deactivated groups are non-reactive in respect of the second reagent that comprises functionalities.
  • the first reagent may also be denoted a "deactivating agent".
  • the diffusion is controlled to gradually decrease towards the centre, and hence there will be an increasing capability to couple functional groups and provide ligands towards the further in you get. Since the number of available groups have been controlled by the deactivation step, in the second step, the amount of reagent is not cru- cial and there will be no need to control diffusion in the second step.
  • said at least two different functionalities are present on different ligand kinds, and a separate chemical gradient is provided for each such ligand kind within the support.
  • a separate chemical gradient is provided for each such ligand kind within the support.
  • Such different gradients may be as discussed above in the context of the first aspect of the invention.
  • two chemical gradients are provided in the support, one of which is a ligand density gradient. The effects and advantages of such gradients and combinations of gradients will be discussed in more detail below in the context of the process of liquid chromatography.
  • Figure 7E shows two gradients of opposite direction within the support
  • Figure 7F shows two gradients of the same direction but of different inclination within the support
  • Figure 7G illustrates two gradients, one is in the centre of the particle and one surrounding the centre, similar to Figure 7C
  • Figure 7H shows a support, wherein one ligand or functionality describes a planar curve and the other is a gradient similar to the one described in Figure 7B.
  • a support having the kind of gradients shown in Figure 7H can e.g. be obtained by starting from a support material which has already been functionalised with ligand to a constant substitution degree and subsequently applying the method according to the invention to provide a gradient.
  • Example 3 Positive gradient provided in toluene/water system (U1282081A
  • a separation matrix comprising a density gradient of carboxymethyl (CM) cation-exchange ligands was prepared as follows.
  • the gel was washed with 3x 30 ml of distilled water and transferred to a reaction vial containing a solution of 3-mercaptopropionic acid (1.5 ml) in water (5 ml) that had been adjusted to pH 12.5 by addition of a 50% aq. solution of NaOH. The reaction was left 16 hours under stirring at 50°C. After filtration of the reaction mixture, the gel was washed with 3x 30 ml of distilled water. Titration was used to confirm the average substitution degree, while the presence of ligand gradients is confirmed as below.
  • Nd3+ versus lateral position.
  • the intensity is high at the outer parts of a bead but gradually decreases when going into the middle of the bead, and finally levels off and/or becomes to low to be measured. In this case (and further on), measurements were done only about one radius of the beads.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Treatment Of Liquids With Adsorbents In General (AREA)
PCT/SE2004/001583 2003-10-31 2004-11-01 Novel separation matrix Ceased WO2005042131A1 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
US10/575,945 US20070125711A1 (en) 2003-10-31 2004-11-01 Novel separation matrix
JP2006537940A JP2007510153A (ja) 2003-10-31 2004-11-01 新規分離マトリックス
EP04800246A EP1677887A1 (en) 2003-10-31 2004-11-01 Novel separation matrix
US12/692,671 US8070958B2 (en) 2003-10-31 2010-01-25 Separation matrix having a ligand density gradient

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE0302911A SE0302911D0 (sv) 2003-10-31 2003-10-31 Novel separation matrix
SE0302911-3 2003-10-31

Related Child Applications (2)

Application Number Title Priority Date Filing Date
US10/575,945 A-371-Of-International US20070125711A1 (en) 2003-10-31 2004-11-01 Novel separation matrix
US12/692,671 Division US8070958B2 (en) 2003-10-31 2010-01-25 Separation matrix having a ligand density gradient

Publications (1)

Publication Number Publication Date
WO2005042131A1 true WO2005042131A1 (en) 2005-05-12

Family

ID=29580205

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/SE2004/001583 Ceased WO2005042131A1 (en) 2003-10-31 2004-11-01 Novel separation matrix

Country Status (5)

Country Link
US (2) US20070125711A1 (https=)
EP (1) EP1677887A1 (https=)
JP (2) JP2007510153A (https=)
SE (1) SE0302911D0 (https=)
WO (1) WO2005042131A1 (https=)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103382215A (zh) * 2012-03-12 2013-11-06 默克专利股份有限公司 以流通方式从生物药物制剂中去除蛋白质聚集体
WO2015088677A1 (en) * 2013-12-12 2015-06-18 Emd Millipore Corporation Protein separations using an acrylamide containing filter
US9308520B2 (en) * 2005-12-16 2016-04-12 Akzo Nobel N.V. Silica based material

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE0502485L (sv) * 2005-11-09 2007-05-10 Peter Viberg Partiklar
US8079964B2 (en) * 2008-02-25 2011-12-20 Devicor Medical Products, Inc. Method and apparatus for inserting biopsy site marker in marker body
WO2010005364A1 (en) * 2008-07-08 2010-01-14 Ge Healthcare Bio-Sciences Ab Separation medium for chromatography of various biomolecules
WO2011046494A1 (en) * 2009-10-12 2011-04-21 Ge Healthcare Bio-Sciences Ab Separation matrices
WO2011136721A1 (en) * 2010-04-26 2011-11-03 Ge Healthcare Bio-Sciences Ab Method for production of chromatography media
SG195306A1 (en) * 2011-06-08 2013-12-30 Agency Science Tech & Res Purification of biological products by constrained cohydration chromatography
WO2015137860A1 (en) * 2014-03-14 2015-09-17 Ge Healthcare Bio-Sciences Ab Separation matrices for purification of biological particles

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5561097A (en) * 1994-04-28 1996-10-01 Minnesota Mining And Manufacturing Company Method of controlling density of ligand coupled onto supports and products produced therefrom
US5977345A (en) * 1998-03-03 1999-11-02 Virginia Tech Intellectual Properties, Inc Inside-out crosslinked and commercial-scale hydrogels, and sub-macromolecular selective purification using the hyrdogels
US6426315B1 (en) * 1997-03-04 2002-07-30 Amersham Pharmacia Biotech Ab Process for introducing a functionality
US6528322B1 (en) * 1999-08-06 2003-03-04 Pharmacia Ab Analytical method and apparatus

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3983299A (en) * 1974-03-04 1976-09-28 Purdue Research Foundation Bonded carbohydrate stationary phases for chromatography
US5652348A (en) 1994-09-23 1997-07-29 Massey University Chromatographic resins and methods for using same
SE9600590D0 (sv) * 1996-02-19 1996-02-19 Pharmacia Biotech Ab Sätt för kromatografisk separation av peptider och nukleinsyra samt ny högaffin jonbytesmatris
US6258548B1 (en) * 1997-06-05 2001-07-10 A-Fem Medical Corporation Single or multiple analyte semi-quantitative/quantitative rapid diagnostic lateral flow test system for large molecules
AU2002237206A1 (en) 2001-03-07 2002-09-19 Nkt Research A/S Method for the manufacture of gradient gels and method for analysing biomolecules on ultra-long ipg gels

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5561097A (en) * 1994-04-28 1996-10-01 Minnesota Mining And Manufacturing Company Method of controlling density of ligand coupled onto supports and products produced therefrom
US6426315B1 (en) * 1997-03-04 2002-07-30 Amersham Pharmacia Biotech Ab Process for introducing a functionality
US5977345A (en) * 1998-03-03 1999-11-02 Virginia Tech Intellectual Properties, Inc Inside-out crosslinked and commercial-scale hydrogels, and sub-macromolecular selective purification using the hyrdogels
US6528322B1 (en) * 1999-08-06 2003-03-04 Pharmacia Ab Analytical method and apparatus

Cited By (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9308520B2 (en) * 2005-12-16 2016-04-12 Akzo Nobel N.V. Silica based material
CN103382215A (zh) * 2012-03-12 2013-11-06 默克专利股份有限公司 以流通方式从生物药物制剂中去除蛋白质聚集体
EP2639239A3 (en) * 2012-03-12 2013-11-20 Merck Patent GmbH Removal of Protein Aggregates from Biopharmaceutical Preparations in a Flow-Through Mode
CN104817611A (zh) * 2012-03-12 2015-08-05 默克专利股份有限公司 以流通方式从生物药物制剂中去除蛋白质聚集体
CN103382215B (zh) * 2012-03-12 2016-08-24 默克专利股份有限公司 以流通方式从生物药物制剂中去除蛋白质聚集体
CN104817611B (zh) * 2012-03-12 2019-06-18 默克专利股份有限公司 以流通方式从生物药物制剂中去除蛋白质聚集体
WO2015088677A1 (en) * 2013-12-12 2015-06-18 Emd Millipore Corporation Protein separations using an acrylamide containing filter
CN105980047A (zh) * 2013-12-12 2016-09-28 Emd密理博公司 使用含丙烯酰胺的过滤器分离蛋白
US9951101B2 (en) 2013-12-12 2018-04-24 Emd Millipore Corporation Protein separations using an acrylamide containing filter
CN105980047B (zh) * 2013-12-12 2019-01-04 Emd密理博公司 使用含丙烯酰胺的过滤器分离蛋白
US10570171B2 (en) 2013-12-12 2020-02-25 Emd Millipore Corporation Protein separations using an acrylamide containing filter

Also Published As

Publication number Publication date
JP2007510153A (ja) 2007-04-19
US20100130354A1 (en) 2010-05-27
US20070125711A1 (en) 2007-06-07
SE0302911D0 (sv) 2003-10-31
JP2012037530A (ja) 2012-02-23
EP1677887A1 (en) 2006-07-12
US8070958B2 (en) 2011-12-06

Similar Documents

Publication Publication Date Title
US8070958B2 (en) Separation matrix having a ligand density gradient
CA2280004C (en) An adsorption/separation method and a medium for adsorption/separation
Turiel et al. Molecularly imprinted polymers: towards highly selective stationary phases in liquid chromatography and capillary electrophoresis
KR102868557B1 (ko) 대기공 아가로스
CN102015094B (zh) 层析介质
Leonard New packing materials for protein chromatography
US6426315B1 (en) Process for introducing a functionality
US10562007B2 (en) Separation matrix
JP5596560B2 (ja) 分離媒体の製造方法
US9155980B2 (en) Separation medium for chromatography of various biomolecules
JP5826180B2 (ja) 分離マトリックス
JP2007531891A (ja) 分離マトリックスの製造方法
Ali et al. Monolithic silica stationary phases in liquid chromatography
EP1937403B1 (en) Manufacture of chromatography matrices
WO2005073711A2 (en) Chromatographic material for the absorption of proteins at physiological ionic strength
Unger et al. Bonded Silica Phases for the Separation of Biopolymers by Means of Column Liquid Chromatography
Ali et al. A simple and cost-effective hybrid stationary phase for the separation of peptides, proteins and benzene derivatives through liquid chromatography
Fernández‐Lahore et al. Ceramic‐Based Adsorbents in Bioproduct Recovery and Purification
Svec Organic Polymer Support Materials

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DPEN Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed from 20040101)
WWE Wipo information: entry into national phase

Ref document number: 2004800246

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 2007125711

Country of ref document: US

Ref document number: 10575945

Country of ref document: US

WWE Wipo information: entry into national phase

Ref document number: 2006537940

Country of ref document: JP

WWP Wipo information: published in national office

Ref document number: 2004800246

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 10575945

Country of ref document: US